Prognostic value of ERCC1, RRM1, and TS proteins in patients with resected non-small cell lung cancer

Cancer Chemotherapy and Pharmacology
Yu-Wen HeJianxing He

Abstract

Recent clinical trials showed that expression of excision repair cross-complementation group 1 (ERCC1), ribonucleotide reductase M1 (RRM1), and thymidylate synthase (TS) proteins was able to predict the effects of non-small cell lung cancer (NSCLC) to chemotherapy. However, it remains unknown whether the adjuvant chemotherapy based on expression of the three proteins has survival significance in Chinese NSCLC patients. We investigated 128 Chinese patients receiving chemotherapy after tumor resection for expression of these proteins using immunohistochemistry. Based on protein expression, patients were assigned to two groups for different adjuvant chemotherapy regimes. The disease-free survival (DFS) data were collected and analyzed using Kaplan-Meier curves and Cox models. We found that DFS of these patients with carboplatin and a third-generation agent (gemcitabine or pemetrexed) stratified by protein expression showed no statistical difference between individual treatment versus non-individuation treatment analyzed using Kaplan-Meier method (P = 0.143, median 23.9 vs. 30.8 months). Furthermore, the multivariate analysis showed that histology and tumor stages were independent predictors for DFS in these patients. The results s...Continue Reading

Associated Clinical Trials

References

Aug 31, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M FukushimaT Takechi
Jan 23, 2004·The New England Journal of Medicine·Rodrigo ArriagadaUNKNOWN International Adjuvant Lung Cancer Trial Collaborative Group
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rafael RosellUNKNOWN Spanish Lung Cancer Group
Sep 8, 2006·The New England Journal of Medicine·Ken A OlaussenUNKNOWN IALT Bio Investigators
May 31, 2007·Current Opinion in Pulmonary Medicine·Ken André OlaussenJean-Charles Soria
Nov 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rodrigo ArriagadaThierry Le Chevalier
Aug 4, 2010·Anti-cancer Drugs·Sandra GeigerHans Joachim Stemmler
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
May 21, 2011·Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·Ekrem Cengiz SeyhanNeslihan Fener
Jul 12, 2011·Revue des maladies respiratoires·I Rouquette, J Mazieres
Jul 14, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Luc FribouletJean-Charles Soria
Sep 3, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Martin Filipits, Robert Pirker
Jun 12, 2012·Current Medicinal Chemistry·A PassaroE Cortesi
Jul 17, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Eva SodjaTanja Cufer
Aug 15, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wen ZhangJiangyang Lu
Jan 29, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Paula McCloskeyMary O'Brien
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Benjamin BesseJean-Charles Soria
Mar 9, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Martin K H MausDavid R Gandara
Mar 22, 2013·The New England Journal of Medicine·Luc FribouletJean-Charles Soria
Mar 26, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Seung Hyeun LeeKwang Ho In
May 7, 2013·Cancer Chemotherapy and Pharmacology·Sara De DossoMilo Frattini
May 22, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerold BeplerJuergen R Fischer
Jun 1, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Marianne C NicolsonKeith M Kerr
Sep 3, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Helen VassalouDimitris Mavroudis
Dec 3, 2013·European Respiratory Review : an Official Journal of the European Respiratory Society·Emmanuel BergotGérard Zalcman
Jan 7, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Anne-Claire ToffartElisabeth Brambilla

❮ Previous
Next ❯

Citations

Nov 2, 2017·The Journal of Clinical Endocrinology and Metabolism·Judith E K HenningCristina L Ronchi
Nov 18, 2017·Cancer Chemotherapy and Pharmacology·Bolag AltanKen Shirabe
Mar 6, 2019·Current Topics in Medicinal Chemistry·Vadim V Tarasov TarasovGjumrakch Aliev
Nov 29, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Siow Ming LeeAllan Hackshaw

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.